The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium
Open accessAbstract
Context: Prevalence data are important for assessing the burden of disease on the health care system; data on pituitary adenoma prevalence are very scarce. Objective: The objective of the study was to measure the prevalence of clinically relevant pituitary adenomas in a well-defined population. Design: This was a cross-sectional, intensive, case-finding study performed in three regions of the province of Liège, Belgium, to measure pituitary adenoma prevalence as of September 30, 2005. Setting: The study was conducted in specialist and general medical practitioner patient populations, referral hospitals, and investigational centers. Methods: Three demographically and geographically distinct districts of the province of Liège were delineated precisely using postal codes. Medical practitioners in these districts were recruited, and patients with pituitary adenomas under their care were identified. Diagnoses were confirmed after retrieval of clinical, hormonal, radiological, and pathological data; full demographic and therapeutic follow-up data were collected in all cases. Results: Sixty-eight patients with clinically relevant pituitary adenomas were identified in a population of 71,972 individuals; the mean (± sd) prevalence was 94 ± 19.3 cases per 100,000 population (95% confidence interval, 72.2 to 115.8). The group was 67.6% female and had a mean age at diagnosis of 40.3 yr; 42.6% had macroadenomas and 55.9% underwent surgery. Prolactinomas comprised 66% of the group, with the rest having nonsecreting tumors (14.7%), somatotropinomas (13.2%), or Cushing’s disease (5.9%); 20.6% had hypopituitarism. Conclusion: The prevalence of pituitary adenomas in the study population (one case in 1064 individuals) was more than 3.5–5 times that previously reported. This increased prevalence may have important implications when prioritizing funding for research and treatment of pituitary adenomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The prevalence of pituitary adenomas: A systematic review
Ezzat, S., Asa, S. L., Couldwell, W. T., Barr, C. E., Dodge, W. E., Vance, M. L., & McCutcheon, I. E. (2004) · Cancer · doi:10.1002/cncr.20412 · Cited by 1,345
Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T. M. L., Salmela, P. I., Paschke, R., et al. (2006) · Science · doi:10.1126/science.1126100 · Cited by 618
Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study
Vergès, B., Boureille, F., Goudet, P., Murat, A., Beckers, A., Sassolas, G., Cougard, P., Chambe, B., Montvernay, C., & Calender, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8145 · Cited by 483
Self-citationAge‐related and gender‐related occurrence of pituitary adenomas
Mindermann, T., & Wilson, C. B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02557.x · Cited by 304
The Epidemiology of Prolactinomas
Ciccarelli, A., Daly, A. F., & Beckers, A. (2005) · Pituitary · doi:10.1007/s11102-005-5079-0 · Cited by 286
Self-citationPituitary tumors: pathophysiology, clinical manifestations and management.
Arafah, B. M., & Nasrallah, M. P. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080287 · Cited by 207
Davis, F. G., Kupelian, V. A., Freels, S. A., McCarthy, B. J., & Surawicz, T. S. (2001) · Neuro-Oncology · doi:10.1093/neuonc/3.3.152 · Cited by 204
Pituitary Adenomas in Sweden between 1958 and 1991: Incidence, Survival, and Mortality
Nilsson, B., Gustavson‐Kadaka, E., Bengtsson, B., & Jönsson, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6498 · Cited by 173
Estimation and projections of cancer prevalence from cancer registry data
Verdecchia, A., Angelis, G. D., & Capocaccia, R. (2002) · Statistics in Medicine · doi:10.1002/sim.1304 · Cited by 120
Pituitary Adenomas in Sweden between 1958 and 1991: Incidence, Survival, and Mortality
Nilsson, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.4.1420 · Cited by 107
Cited by
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Fernandez, A., Karavitaki, N., & Wass, J. A. H. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03667.x · Cited by 1,115
Diagnosis and Treatment of Pituitary Adenomas: A Review
Molitch, M. E. (2017) · JAMA · doi:10.1001/jama.2016.19699 · Cited by 933
Raverot, G., Burman, P., McCormack, A., Heaney, A., Petersenn, S., Popovic, V., Trouillas, J., Dekkers, O. M., & _, _. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0796 · Cited by 595
Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline
Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1048 · Cited by 585
Self-citationChatzellis, E., Alexandraki, K. I., Androulakis, I. I., & Kaltsas, G. (2015) · Neuroendocrinology · doi:10.1159/000371806 · Cited by 572
HYPOPRONOS, T. M. O., Trouillas, J., Roy, P., Sturm, N., Dantony, E., Cortet-Rudelli, C., Viennet, G., Bonneville, J.-F., Assaker, R., Auger, C., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1084-y · Cited by 545
Incidence of Pituitary Adenomas in Northern Finland in 1992–2007
Raappana, A., Koivukangas, J., Ebeling, T., & Pirilä, T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0537 · Cited by 470
Pathogenesis of pituitary tumors
Melmed, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.40 · Cited by 466
Overview of the 2017 WHO Classification of Pituitary Tumors
Mete, O., & Lopes, M. B. (2017) · Endocrine Pathology · doi:10.1007/s12022-017-9498-z · Cited by 460
Colao, A., Grasso, L. F. S., Giustina, A., Melmed, S., Chanson, P., Pereira, A. M., & Pivonello, R. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0071-6 · Cited by 396
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Daly, A. F., Tichomirowa, M. A., Petrossians, P., Heliövaara, E., Jaffrain-Rea, M.-L., Barlier, A., Naves, L. A., Ebeling, T., Karhu, A., Raappana, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2556 · Cited by 384
Self-citationSystemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Beckers, A., Aaltonen, L. A., Daly, A. F., & Karhu, A. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1013 · Cited by 360
Self-citationThe epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study
Agustsson, T. T., Baldvinsdottir, T., Jonasson, J. G., Olafsdottir, E., Steinthorsdottir, V., Sigurdsson, G., Thorsson, A. V., Carroll, P. V., Korbonits, M., & Benediktsson, R. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0189 · Cited by 347
de Robles, P., Fiest, K. M., Frolkis, A. D., Pringsheim, T., Atta, C., St. Germaine-Smith, C., Day, L., Lam, D., & Jette, N. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou283 · Cited by 338
Diagnosis and Management of Pituitary Adenomas: A Review
Tritos, N. A., & Miller, K. K. (2023) · JAMA · doi:10.1001/jama.2023.5444 · Cited by 331
Daly, A. F., Vanbellinghen, J.-F., Khoo, S. K., Jaffrain-Rea, M.-L., Naves, L. A., Guitelman, M. A., Murat, A., Emy, P., Gimenez-Roqueplo, A.-P., Tamburrano, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2513 · Cited by 326
Self-citationThe Epidemiology of Pituitary Adenomas
Daly, A. F., & Beckers, A. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.04.002 · Cited by 325
Self-citationClinical Biology of the Pituitary Adenoma
Melmed, S., Kaiser, U. B., Lopes, M. B., Bertherat, J., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 321
Self-citationEpidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas
Ntali, G., & Wass, J. A. (2018) · Pituitary · doi:10.1007/s11102-018-0869-3 · Cited by 285
Beck-Peccoz, P., Lania, A., Beckers, A., Chatterjee, K., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000351007 · Cited by 283
Self-citationAcromegaly: pathogenesis, diagnosis, and management
Fleseriu, M., Langlois, F., Lim, D. S. T., Varlamov, E. V., & Melmed, S. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00244-3 · Cited by 279
The incidence rate of pituitary adenomas in western Sweden for the period 2001–2011
Tjörnstrand, A., Gunnarsson, K., Evert, M., Holmberg, E., Ragnarsson, O., Rosén, T., & Filipsson Nyström, H. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0144 · Cited by 272
Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database
Petrossians, P., Daly, A. F., Natchev, E., Maione, L., Blijdorp, K., Sahnoun-Fathallah, M., Auriemma, R., Diallo, A. M., Hulting, A.-L., Ferone, D., et al. (2017) · Endocrine-Related Cancer · doi:10.1530/erc-17-0253 · Cited by 263
Self-citation(2011) · Endocrine Practice · doi:10.4158/ep.17.s4.1 · Cited by 259
Famini, P., Maya, M. M., & Melmed, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0168 · Cited by 258
Feelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 256
Hyperprolactinemia and Prolactinomas
Mancini, T., Casanueva, F. F., & Giustina, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.013 · Cited by 256
National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden
Önnestam, L., Berinder, K., Burman, P., Dahlqvist, P., Engström, B. E., Wahlberg, J., & Nyström, H. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3362 · Cited by 148
Mazziotti, G., Mancini, T., Mormando, M., De Menis, E., Bianchi, A., Doga, M., Porcelli, T., Vescovi, P. P., De Marinis, L., & Giustina, A. (2011) · Pituitary · doi:10.1007/s11102-011-0293-4 · Cited by 98
“PRL-secreting adenomas are the most common type of secretory pituitary tumors accounting for about 40–60% of all pituitary adenomas [3, 4].”
BackgroundFleseriu, M., Hamrahian, A. H., Hoffman, A. R., Kelly, D. F., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161512.dscr · Cited by 68
Ntali, G., Capatina, C., Fazal-Sanderson, V., Byrne, J. V., Cudlip, S., Grossman, A. B., Wass, J. A. H., & Karavitaki, N. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0967 · Cited by 64
Growth hormone deficiency in treated acromegaly
Mazziotti, G., Marzullo, P., Doga, M., Aimaretti, G., & Giustina, A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.10.005 · Cited by 33
Prolactin in Human Reproduction
Molitch, M. E. (2009) · Yen & Jaffe's Reproductive Endocrinology · doi:10.1016/b978-1-4160-4907-4.00003-6 · Cited by 31
Metadata
- Authors
- Daly, A. F., Rixhon, M., Adam, C., Dempegioti, A., Tichomirowa, M. A., & Beckers, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-12-01
- Volume
- 91
- Issue
- 12
- Pages
- 4769-4775
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2132094049
- Cited by
- 1,025
- References
- 13
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.